Volume 73, Issue 5 (August 2015)                   Tehran Univ Med J 2015, 73(5): 334-344 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Arab Zozani M, Hosseini S A, Akbari Sari A, Mahdavi-Mazdeh M, Majdzadeh S R, Velayati A. Safety and effectiveness of everolimus compared with sirolimus and tacrolimus in preventing kidney transplantation rejection: a systematic review and meta-analysis. Tehran Univ Med J. 2015; 73 (5) :334-344
URL: http://tumj.tums.ac.ir/article-1-6782-en.html
1- Department of Health Technology Assessment, Tehran University of Medical Sciences, Tehran, Iran.
2- Committee of Clinical Research, Food and Drug Administration, Tehran, Iran.
3- Department of Health Management and Economics, Tehran University of Medical Sciences, Tehran, Iran. , akbarisari@tums.ac.ir
4- Tissue Bank and Research Center, Tehran University of Medical Sciences, Tehran, Iran.
5- National Institute for Health Research, Tehran University of Medical Sciences, Tehran, Iran.
6- Department of Educational Management, Economics and Policy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract:   (8061 Views)
Background: Everolimus is an immunosuppressive agent with a novel mode of action but has a different clinical role with calcineurin inhibitors (CNI). The aim of this study was to evaluate the safety and effectiveness of everolimus compared with sirolimus and tacrolimus in preventing kidney transplantation rejection. Methods: Search was conducted for finding randomized clinical trials (RCT) until the end of 2013 in main databases include Cochrane, Medline and other related databases in February 2014. To find the ongoing trials two databases were searched (Clinicaltrial.gov and irct.ir/fa/). Two independent reviewers checked studies for quality and eligibility and finally extracted the data. Data extraction was performed using Cochrane data extraction form for clinical trial. Discrepancies were resolved via consultation with third person. The studies examined in term of heterogeneity with I2 and Chi-square test. The mata-analysis was carried out using RevMan 5.2 (Wintertree Software Inc, Ontario, Canada) when there was homogeneity. Results: Finally, seven reports from six RCTs included in this study. All reports were in english language and total numbers of participant in these studies were 824. No studies were found in comparison of everolimus and sirolimus and all seven reports were combination of everolimus, tacrolimus and other relative drugs. Follow up time of studies were different from 6 to 36 months. Due to the heterogeneity of included studies, only two studies were entered into meta-analysis. The recorded mean values for glomerular filtration rate, serum creatinine and creatinine clearance were between 60-80 ml/min, 50 to 80 ml/min and 1.2 to 1.9 mg/dl respectively. The results of meta-analysis in three outcomes include serum creatinine, creatinine clearance and glomerular filtration rate were significantly in favor of low dose tacrolimus plus everolimus. Conclusion: In general, everolimus showed better results in combination with tacrolimus. Given the available evidence in this study, everolimus in combination with low dose tacrolimus showed better safety and effectiveness in preventing kidney transplantation rejection.
Full-Text [PDF 472 kb]   (2984 Downloads)    
Type of Study: Original Article |

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


© 2020 All Rights Reserved | Tehran University Medical Journal TUMS Publications

Designed & Developed by : Yektaweb